Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998–2000
- 31 May 2002
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 43 (1), 65-73
- https://doi.org/10.1016/s0732-8893(02)00371-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the NetherlandsClinical Microbiology & Infection, 2001
- Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparisonJournal of Antimicrobial Chemotherapy, 2001
- Surveillance of antimicrobial resistance — what, how and whither?Clinical Microbiology & Infection, 2001
- Clinical Prevalence, Antimicrobial Susceptibility, and Geographic Resistance Patterns of Enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Vancomycin-Intermediate and -Resistant Staphylococcus aureus: What the Infectious Disease Specialist Needs to KnowClinical Infectious Diseases, 2001
- Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolidJournal of Antimicrobial Chemotherapy, 2000
- OxazolidinonesDrugs, 2000
- Association Between Decreased Susceptibility to a New Antibiotic for Treatment of Human Diseases, Everninomicin (SCH 27899), and Resistance to an Antibiotic Used for Growth Promotion in Animals, AvilamycinMicrobial Drug Resistance, 1998
- Emergence of Increased Resistance to Quinupristin/ Dalfopristin During Therapy for Enterococcus faecium BacteremiaClinical Infectious Diseases, 1997
- Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsJournal of Medicinal Chemistry, 1996